XSTOKONT
Market cap8mUSD
Dec 23, Last price
2.64SEK
1D
-4.35%
1Q
6.45%
Jan 2017
-31.43%
IPO
-63.83%
Name
Kontigo Care AB
Chart & Performance
Profile
Kontigo Care AB (publ) provides health care solutions for addiction treatment in Sweden. It offers Previct Alcohol, a digital medical device for the treatment of alcohol dependence; and Previct Gambling, a digital tool for the treatment of gambling addiction. The company was incorporated in 2013 and is headquartered in Uppsala, Sweden.
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 28,948 1.80% | 28,435 15.86% | 24,543 20.44% | |||||||
Cost of revenue | (12,093) | (7,525) | 8,546 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 41,041 | 35,960 | 15,998 | |||||||
NOPBT Margin | 141.77% | 126.46% | 65.18% | |||||||
Operating Taxes | 5 | 47 | ||||||||
Tax Rate | 0.01% | 0.29% | ||||||||
NOPAT | 41,041 | 35,955 | 15,951 | |||||||
Net income | 212 -92.68% | 2,895 -341.40% | (1,199) -6.56% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 9,150 | 4,125 | ||||||||
BB yield | -13.91% | -3.03% | ||||||||
Debt | ||||||||||
Debt current | 2,275 | (4,193) | (5,015) | |||||||
Long-term debt | 3,675 | 1 | ||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 2,213 | (1) | ||||||||
Net debt | (3,902) | (9,935) | (13,493) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 5,972 | 7,299 | 4,608 | |||||||
CAPEX | (1,692) | (9,496) | (4,335) | |||||||
Cash from investing activities | (16,730) | (9,496) | (4,335) | |||||||
Cash from financing activities | 14,868 | (540) | 3,268 | |||||||
FCF | 35,394 | 37,407 | 18,828 | |||||||
Balance | ||||||||||
Cash | 9,852 | 5,742 | 8,479 | |||||||
Long term investments | ||||||||||
Excess cash | 8,405 | 4,320 | 7,252 | |||||||
Stockholders' equity | (55,691) | (56,319) | (59,214) | |||||||
Invested Capital | 92,359 | 73,530 | 72,660 | |||||||
ROIC | 49.48% | 49.19% | 21.62% | |||||||
ROCE | 111.93% | 208.94% | 118.98% | |||||||
EV | ||||||||||
Common stock shares outstanding | 24,450 | 23,822 | 23,697 | |||||||
Price | 2.69 -35.02% | 4.14 -27.87% | 5.74 10.81% | |||||||
Market cap | 65,770 -33.31% | 98,623 -27.49% | 136,018 13.81% | |||||||
EV | 61,868 | 88,688 | 122,525 | |||||||
EBITDA | 42,215 | 37,198 | 17,194 | |||||||
EV/EBITDA | 1.47 | 2.38 | 7.13 | |||||||
Interest | 408 | 10 | 47 | |||||||
Interest/NOPBT | 0.99% | 0.03% | 0.29% |